#79- Platforms, patients & pipelines at JPM

The coffee break biotech roundup, by SomX.

Jan 17 • Daisy Makin and Belle Taylor

1

2

#78 - Sleep prophecies, clinical conjuring, and corporate clairvoyance

The coffee break biotech roundup, by SomX.

Jan 10 • Andrew, Belle Taylor, and Daisy Makin

1

1

December 2025

#77 - Yuletide isotopes, venture stockings, and the hunger helper

The coffee break biotech roundup, by SomX.

Dec 20, 2025 • Daisy Makin and Belle Taylor

2

3

#76 - Fungal fowl, fertility failings and Parkinsons in our pipes

The coffee break biotech roundup, by SomX.

Dec 13, 2025 • Andrew, Daisy Makin, and Belle Taylor

1

1

#75 – Policy shifts, GLP plateaus, and pattern baldness

The coffee break biotech roundup, by SomX.

Dec 8, 2025 • Daisy Makin and Jessica Smith

1

November 2025

#74 - Enzymes, espionage, and experimental excrement

The coffee break biotech roundup, by SomX.

Nov 29, 2025 • Andrew and Daisy Makin

3

#73 – Superbug Turkeys, Venom Cures and Camel Antibodies

The coffee break biotech roundup, by SomX.

Nov 22, 2025 • Andrew and Belle Taylor

2

3

#72 - The real housewives of bidding wars, regulations, and CRISPR

The coffee break biotech roundup, by SomX.

Nov 15, 2025 • Daisy Makin and Belle Taylor

1

1

#71 - Gut instincts, artificial wombs, and the UK brain drain

The coffee break biotech roundup, by SomX.

Nov 9, 2025 • Andrew

1

#70 – Trick or treat?! Discount drugs and the secrets of eternal youth

The coffee break biotech roundup, by SomX.

Nov 1, 2025 • Andrew

3

1

October 2025

#69 - Collapsing trials, clever pigs & cutthroat exits

The coffee break biotech roundup, by SomX.

Oct 25, 2025 • Andrew

#68 – Heatproof bugs, high-yield bonds & herpes vectors

The coffee break biotech roundup, by SomX.

Oct 18, 2025 • Daisy Makin and Belle Taylor

1